Prognostic Value of Combined Analysis of CTLA-4 and PLR in Esophageal Squamous Cell Carcinoma (ESCC) Patients

Prognostic Value of Combined Analysis of CTLA-4 and PLR in Esophageal Squamous Cell Carcinoma (ESCC) Patients

Objective. The purpose of this study was to evaluate the prognostic role of the cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4) expression level and the platelet lymphocyte ratio (PLR) level in esophageal squamous cell carcinoma (ESCC) patients. Methods. 84 ESCC patients who received surgical t...

Full description

Bibliographic Details
Main Authors:	Cui-Ying Zhang, Juan Zhang, Yun-Fan Ma, Hong Zhe, Ren Zhao, Yan-Yang Wang
Format:	Article
Language:	English
Published:	Hindawi Limited 2019-01-01
Series:	Disease Markers
Online Access:	http://dx.doi.org/10.1155/2019/1601072

Similar Items

The Role of Genetic factors in Susceptibility to Esophageal Squamous Cell Carcinoma (ESCC)
by: Akbari, Mohammadreza Jr.
Published: (2011)

The Role of Genetic factors in Susceptibility to Esophageal Squamous Cell Carcinoma (ESCC)
by: Akbari, Mohammadreza Jr.
Published: (2011)

A Mechanistic Study of Acquired Cisplatin Resistance in Esophageal Squamous Cell Carcinoma (ESCC)
Published: (2016)

Elevated maspin expression is associated with better overall survival in esophageal squamous cell carcinoma (ESCC).
by: Yang Wang, et al.
Published: (2013-01-01)

CCGD-ESCC: A Comprehensive Database for Genetic Variants Associated with Esophageal Squamous Cell Carcinoma in Chinese Population
by: Linna Peng, et al.
Published: (2018-08-01)

Polymorphisms in the ERCC5 gene and risk of esophageal squamous cell carcinoma (ESCC) in Eastern Chinese populations.
by: Mei-Ling Zhu, et al.
Published: (2012-01-01)

Chrysin serves as a novel inhibitor of DGKα/FAK interaction to suppress the malignancy of esophageal squamous cell carcinoma (ESCC)
by: Jie Chen, et al.
Published: (2021-01-01)

Correction: Elevated Maspin Expression Is Associated with Better Overall Survival in Esophageal Squamous Cell Carcinoma (ESCC)
by: The Staff
Published: (2014-01-01)

Correction: Elevated Maspin Expression Is Associated with Better Overall Survival in Esophageal Squamous Cell Carcinoma (ESCC).
Published: (2014-01-01)

The clinical use of pretreatment NLR, PLR, and LMR in patients with esophageal squamous cell carcinoma: evidence from a meta-analysis
by: Sun Y, et al.
Published: (2018-11-01)

79 Tumor-immune signatures associated with response or resistance to tislelizumab (Anti-PD-1) in esophageal squamous cell carcinoma (ESCC)
by: Wei Huang, et al.
Published: (2020-11-01)

Cabozantinib (XL184) and R428 (BGB324) Inhibit the Growth of Esophageal Squamous Cell Carcinoma (ESCC)
by: Pei-Wen Yang, et al.
Published: (2019-11-01)

Nrf2 promotes esophageal squamous cell carcinoma (ESCC) resistance to radiotherapy through the CaMKIIα-associated activation of autophagy
by: Di Xia, et al.
Published: (2020-07-01)

Targeted bisulfite sequencing identified a panel of DNA methylation-based biomarkers for esophageal squamous cell carcinoma (ESCC)
by: Weilin Pu, et al.
Published: (2017-12-01)

A New Index AGR-PLR Score (APS) for Patients with Esophageal Squamous Cell Carcinoma Undergoing Radical Esophagectomy
by: Yao Y, et al.
Published: (2021-08-01)

Combination of meta-analysis and graph clustering to identify prognostic markers of ESCC
by: Hongyun Gao, et al.
Published: (2012-01-01)

Prognostic value of PLR in various cancers: a meta-analysis.
by: Xin Zhou, et al.
Published: (2014-01-01)

Expression of LncRNA DLEU1 in Esophageal Squamous Cell Carcinoma and Its Effect on Proliferation and Migration of ESCC Cells
by: DUAN Yuqing, et al.
Published: (2021-03-01)

Comparison of Survival Status and Related Risk Factors of Esophageal Squamous Cell Carcinoma Patients Between High- and Low-incidence Areas of ESCC
by: HU Shoujia, et al.
Published: (2019-09-01)

Integrated analysis of genome-wide miRNAs and targeted gene expression in esophageal squamous cell carcinoma (ESCC) and relation to prognosis
by: Howard Yang, et al.
Published: (2020-05-01)

Transcriptomic and microRNA Expression Profiles Identify Biomarkers for Predicting Neo-Chemoradiotherapy Response in Esophageal Squamous Cell Carcinomas (ESCC)
by: Jian Wang, et al.
Published: (2021-04-01)

Prognostic value of FoxP3 and CTLA-4 expression in patients with oral squamous cell carcinoma.
by: Kazushige Koike, et al.
Published: (2020-01-01)

Identification of prothymosin alpha (PTMA) as a biomarker for esophageal squamous cell carcinoma (ESCC) by label-free quantitative proteomics and Quantitative Dot Blot (QDB)
by: Yanping Zhu, et al.
Published: (2019-04-01)

Effects of Polygonatum sibiricum Polysaccharides (PSP) on Human Esophageal Squamous Cell Carcinoma (ESCC) via NF-κB Signaling Pathway
by: Weizheng Zhou, et al.
Published: (2019-01-01)

Nicotine activates YAP1 through nAChRs mediated signaling in esophageal squamous cell cancer (ESCC).
by: Yue Zhao, et al.
Published: (2014-01-01)

Identification of Hyper-Methylated Tumor Suppressor Genes-Based Diagnostic Panel for Esophageal Squamous Cell Carcinoma (ESCC) in a Chinese Han Population
by: Chenji Wang, et al.
Published: (2018-09-01)

Prognostic value of systemic inflammatory factors NLR, LMR, PLR and LDH in penile cancer
by: Chen Hu, et al.
Published: (2020-05-01)

Prognostic value of a five-lncRNA signature in esophageal squamous cell carcinoma
by: Lan zhang, et al.
Published: (2020-08-01)

Identification of the Prognostic Value of Tumor Microenvironment-Related Genes in Esophageal Squamous Cell Carcinoma
by: Donglei Zhang, et al.
Published: (2020-12-01)

Expression and prognostic significance of MYL9 in esophageal squamous cell carcinoma.
by: Jian-Hua Wang, et al.
Published: (2017-01-01)

Directional Migration in Esophageal Squamous Cell Carcinoma (ESCC) is Epigenetically Regulated by SET Nuclear Oncogene, a Member of the Inhibitor of Histone Acetyltransferase Complex
by: Xiang Yuan, et al.
Published: (2017-11-01)

High-CLDN4 ESCC cells harbor stem-like properties and indicate for poor concurrent chemoradiation therapy response in esophageal squamous cell carcinoma
by: Cheng-Han Lin, et al.
Published: (2019-09-01)

Promoter hypomethylation mediated upregulation of MicroRNA-10b-3p targets FOXO3 to promote the progression of esophageal squamous cell carcinoma (ESCC)
by: Yi-fang Lu, et al.
Published: (2018-12-01)

Expression and Prognostic Value of Id-4 in Patients with Esophageal Squamous Cell Carcinoma
by: Wang X, et al.
Published: (2020-02-01)

Prognostic Significance of the Combination of Fibrinogen and Tumor Marker Index in Esophageal Squamous Cell Carcinoma Patients
by: Qiao Y, et al.
Published: (2021-02-01)

Prognostic role of NLR, PLR, and LMR in patients with pulmonary embolism
by: Nuri Köse, et al.
Published: (2019-11-01)

Correction to: Promoter hypomethylation mediated upregulation of MicroRNA-10b-3p targets FOXO3 to promote the progression of esophageal squamous cell carcinoma (ESCC)
by: Yi-fang Lu, et al.
Published: (2020-01-01)

Prognostic value of an immunohistochemical signature in patients with esophageal squamous cell carcinoma undergoing radical esophagectomy
by: Jin Meng, et al.
Published: (2018-02-01)

The prognostic value of tumor length to resectable esophageal squamous cell carcinoma: a retrospective study
by: Xiangwei Zhang, et al.
Published: (2017-01-01)

Prognostic value of circulating tumor cells in the peripheral blood of patients with esophageal squamous cell carcinoma
by: Qiao Y, et al.
Published: (2017-03-01)